Top compounds associated with response to CCDC22


Feature Type Standardized
Nominal ANOVA
mRNA pluripotin CTRPv2 pan-cancer AAC -0.1 0.005
mRNA ATRA GDSC1000 pan-cancer AAC 0.099 0.006
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.095 0.006
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.11 0.006
mRNA Cytarabine FIMM pan-cancer AAC -0.43 0.007
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.1 0.007
mRNA ATRA FIMM pan-cancer AAC 0.41 0.007
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.1 0.008
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.009
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
Download CSV